Blindness News and Research

RSS

ACE inhibitors for diabetics cut in half the risk of death

ACE inhibitors, a type of medication often used to treat high blood pressure or heart disease, can lower mortality rates for people who have diabetes -- whether they have cardiovascular disease or not, according to a study published in the June issue of Diabetes Care.

26 May 2004

Toxoplasma gondii discovery may help fight against malaria

University of North Carolina at Chapel Hill scientists have discovered a protein in the cell wall of parasites that’s crucial to the molecular mechanism allowing them to move between cells, survive and cause disease.

25 May 2004

The worldwide prevalence of glaucoma is increasing

Early diagnosis of glaucoma is essential to prevent irreversible visual impairment, according to a Seminar in this week's issue of The Lancet.

20 May 2004

Scientists believe that the dog genome holds a wealth of information that will benefit human health

Recently completed genetic analysis reveals that half of the more than 300 inherited canine disorders — including a number of cancers — resemble specific diseases of man; many scientists believe that the dog genome holds a wealth of information that will benefit human health.

20 May 2004

Damaged metal halide lamps can cause sunburn

Ever think you could get a nasty sunburn — severe enough to peel — by attending an indoor event? Seems improbable, but it can happen. And it has — three times recently in Middle Tennessee.

19 May 2004

Increasing number of cases of wet age-related macular degeneration

Nearly all retina specialists are greatly alarmed by the increasing number of cases of wet age-related macular degeneration (AMD), the leading cause of severe vision loss and blindness in people over the age of 50, and believe the disease will have a serious impact on the public.

11 May 2004

New hope for advances in treatment methods for AIDS, Alzheimer's and age-related blindness

Pharmaceutical science leaders from the FDA, research institutions and top pharmaceutical companies will gather at the 2004 AAPS National Biotechnology Conference, AAPS' spring annual meeting.

4 May 2004

Researchers discover gene responsible for neonatal diabetes

Researchers at Oxford University and the Peninsula Medical School in Exeter have located a gene responsible for around a third of cases of neonatal diabetes. Their findings are likely to lead to treatment of the condition by means of a tablet rather than injections, improving the quality of life of both patients and their parents.

30 Apr 2004

Researchers have discovered the cause of one form of retinitis pigmentosa, a type of genetically inherited blindness

Saint Louis University researchers have discovered the cause of one form of retinitis pigmentosa, a type of genetically inherited blindness.

28 Apr 2004

A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States

A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States and may have led to a doubling of its occurrence during the past 200 years, according to a study by hereditary deafness experts at Virginia Commonwealth University.

27 Apr 2004

Medical students are seeking to uncover a silent killer, glaucoma

Like private eyes, a group of medical students at the College of Medicine are seeking to uncover a silent killer attacking unsuspecting citizens of Tucson: glaucoma.

26 Apr 2004

Improving eye care with telemedicine

Computer scientists at the National Institute of Standards and Technology (NIST) have teamed up with a group of medical professionals to advance the use of telemedicine.

23 Apr 2004

Macular degeneration cause of blindness in older people

Age-related macular degeneration (ARMD) remains the leading cause of blindness in older people, affecting as many as 13 million Americans.

20 Apr 2004

Diabetic eye disease on the rise

With the aging of the population, the number of Americans with major eye diseases is increasing, and vision loss is becoming a major public health problem. By the year 2020, the number of people who are blind or have low vision is projected to increase substantially. These findings appear in the April issue of Archives of Ophthalmology.

15 Apr 2004

Vision loss in over 40's is becoming a major public health problem

12 Apr 2004

Diabetic retinopathy population will quadruple by 2012

Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues, finds that the drug-treated diabetic retinopathy population will quadruple by 2012.

12 Apr 2004

Trial of new drug that may halt progression of Type I Diabetes

The results of a long-term clinical trial on a new drug designed to inhibit the progression of type I diabetes was announced at the International Diabetes Society meeting in Cambridge, England, March 29. The findings of the 18-month long clinical trial confirm the drug's efficacy in improving a diabetic's ability to produce insulin.

30 Mar 2004

Discovery of molecule that is part of the machinery that mediates the sense of hearing

A group of scientists at The Scripps Research Institute, at the University of California in San Diego, and at the Oregon Hearing Research Center and Vollum Institute at Oregon Health & Science University have discovered a key molecule that is part of the machinery that mediates the sense of hearing.

28 Mar 2004

Stem cell research that could help diabetics

University of Florida adult stem cell experts have restored normal blood sugar levels in diabetic mice for three months by chemically coaxing bone marrow cells to produce insulin, a hormone normally made in the pancreas.

22 Mar 2004

New research may help treatment of Norrie disease and familial exudative vitreoretinopathy (FEVR)

Researchers have discovered that genetic mutations underlying two inherited eye disorders arise in different components of a single intracellular signaling pathway that is responsible for development of blood vessels in the eye.